BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27529090)

  • 1. Women's preferences for contralateral prophylactic mastectomy: An investigation using protection motivation theory.
    Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Musiello T; Marven M; Butow P
    Patient Educ Couns; 2016 May; 99(5):814-22. PubMed ID: 27529090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
    Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
    Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting women's intentions for contralateral prophylactic mastectomy: An application of an extended theory of planned behaviour.
    Richards I; Tesson S; Porter D; Phillips KA; Rankin N; Musiello T; Marven M; Butow P
    Eur J Oncol Nurs; 2016 Apr; 21():57-65. PubMed ID: 26952679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.
    Boughey JC; Attai DJ; Chen SL; Cody HS; Dietz JR; Feldman SM; Greenberg CC; Kass RB; Landercasper J; Lemaine V; MacNeill F; Song DH; Staley AC; Wilke LG; Willey SC; Yao KA; Margenthaler JA
    Ann Surg Oncol; 2016 Oct; 23(10):3100-5. PubMed ID: 27469117
    [No Abstract]   [Full Text] [Related]  

  • 5. Practitioner Opinion on Contralateral Prophylactic Mastectomy: How Do We Steer a Patient-Driven Discussion?
    Schellenberg AE; Stypulkowski A; Cordeiro E; Holloway CMB; Eisen A; Scheer AS
    Ann Surg Oncol; 2019 Oct; 26(11):3489-3494. PubMed ID: 31187367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
    Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.
    Schmidt MK; Kelly JE; Brédart A; Cameron DA; de Boniface J; Easton DF; Offersen BV; Poulakaki F; Rubio IT; Sardanelli F; Schmutzler R; Spanic T; Weigelt B; Rutgers EJT
    Eur J Cancer; 2023 Mar; 181():79-91. PubMed ID: 36641897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contralateral prophylactic mastectomy for unilateral breast cancer in women at average risk: Systematic review of patient reported outcomes.
    Srethbhakdi A; Brennan ME; Hamid G; Flitcroft K
    Psychooncology; 2020 Jun; 29(6):960-973. PubMed ID: 32201988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "It felt like unfinished business, it feels like that's finished now": Women's experiences of decision making around contralateral prophylactic mastectomy (CPM).
    Tollow P; Williams VS; Harcourt D; Paraskeva N
    Psychooncology; 2019 Jun; 28(6):1328-1334. PubMed ID: 30963646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
    Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Glazebrook KN; Hieken TJ
    Ann Surg Oncol; 2016 Oct; 23(10):3365-70. PubMed ID: 27364506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and risks of contralateral prophylactic mastectomy in women undergoing treatment for sporadic unilateral breast cancer: a decision analysis.
    Lester-Coll NH; Lee JM; Gogineni K; Hwang WT; Schwartz JS; Prosnitz RG
    Breast Cancer Res Treat; 2015 Jul; 152(1):217-226. PubMed ID: 26062750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgeons' Perspectives of Contralateral Prophylactic Mastectomy.
    Bellavance E; Peppercorn J; Kronsberg S; Greenup R; Keune J; Lynch J; Collyar D; Magder L; Tilburt J; Hlubocky F; Yao K
    Ann Surg Oncol; 2016 Sep; 23(9):2779-87. PubMed ID: 27169770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women's preferences for selective estrogen reuptake modulators: an investigation using protection motivation theory.
    Ralph AF; Ager B; Bell ML; Collins IM; Andrews L; Tucker K; Phillips KA; Butow P
    Patient Educ Couns; 2014 Jul; 96(1):106-12. PubMed ID: 24856850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decisional conflict among breast cancer patients considering contralateral prophylactic mastectomy.
    Manne S; Smith B; Mitarotondo A; Frederick S; Toppmeyer D; Kirstein L
    Patient Educ Couns; 2019 May; 102(5):902-908. PubMed ID: 30553577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Knowledge and Decisions Made for Contralateral Prophylactic Mastectomy: A Survey of Surgeons and Women in the General Population.
    Hooper RC; Hsu J; Duncan A; Bensenhaver JM; Newman LA; Kidwell KM; Chung KC; Momoh AO
    Plast Reconstr Surg; 2019 May; 143(5):936e-945e. PubMed ID: 31033815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer.
    Panchal H; Pilewskie ML; Sheckter CC; Albornoz CR; Razdan SN; Disa JJ; Cordeiro PG; Mehrara BJ; Matros E
    J Surg Oncol; 2019 Jan; 119(1):79-87. PubMed ID: 30480805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.
    Montagna G; Morrow M
    Expert Rev Anticancer Ther; 2020 Mar; 20(3):159-166. PubMed ID: 32077338
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
    Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
    Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redefining Risk and Benefit: Understanding the Decision to Undergo Contralateral Prophylactic Mastectomy.
    Rendle KA; Halley MC; May SG; Frosch DL
    Qual Health Res; 2015 Sep; 25(9):1251-9. PubMed ID: 25371380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of uptake of contralateral prophylactic mastectomy in women with nonhereditary breast cancer.
    Metcalfe KA; Retrouvey H; Kerrebijn I; Butler K; O'Neill AC; Cil T; Zhong T; Hofer SOP; McCready DR
    Cancer; 2019 Nov; 125(22):3966-3973. PubMed ID: 31435939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.